Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Robert Brooks
Chief Executive Officer
robert.brooks@alphageneron.com

Message the company or request a 1:1 meeting here

Alphageneron is a clinical stage biopharma company developing targeted autologous and allogeneic Natural Killer cell and gene therapy, antibody therapeutics, and companion diagnostics. Our Hsp70 NK cell therapy supported by diagnostic, completed a Phase I in Metastatic Colorectal cancer & NSCLC and Phase II clinical tyrial in Advanced in NSCLC. We are planning a Phase II clinical trial in the US in Advanced NSCLC in combination with PD(L)-1 inhibitors.

Pitch Video

Slide Deck